Nonoperating Income (Expense) of INFINITY PHARMACEUTICALS, INC. from 30 Jun 2010 to 30 Jun 2023
- Taxonomy & unit
- us-gaap: USD
- Description
- The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
- Summary
-
INFINITY PHARMACEUTICALS, INC. quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 30 Jun 2010 to 30 Jun 2023.
- INFINITY PHARMACEUTICALS, INC. Nonoperating Income (Expense) for the quarter ending 30 Jun 2023 was $164,000, a 412% increase year-over-year.
- INFINITY PHARMACEUTICALS, INC. Nonoperating Income (Expense) for the twelve months ending 30 Jun 2023 was $1,098,000.
- INFINITY PHARMACEUTICALS, INC. annual Nonoperating Income (Expense) for 2022 was $475,000.
- INFINITY PHARMACEUTICALS, INC. annual Nonoperating Income (Expense) for 2021 was $179,000, a 91% increase from 2020.
- INFINITY PHARMACEUTICALS, INC. annual Nonoperating Income (Expense) for 2020 was $1,995,000, a 38% decline from 2019.
- Source SEC data
- View on sec.gov
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)
INFINITY PHARMACEUTICALS, INC. Quarterly Nonoperating Income (Expense) (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2023 | $1,098,000 | $164,000 | +$132,000 | +412% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $966,000 | $462,000 | +$491,000 | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 09 May 2023 | 2023 | Q1 | |
| Q4 2022 | $475,000 | $308,000 | +$459,000 | 01 Oct 2022 | 31 Dec 2022 | 10-K | 28 Mar 2023 | 2022 | FY | |
| Q3 2022 | $16,000 | $164,000 | +$127,000 | +343% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 14 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $111,000 | $32,000 | +$50,000 | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 10 Aug 2023 | 2023 | Q2 | |
| Q1 2022 | $161,000 | $29,000 | +$18,000 | +38% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2021 | $179,000 | $151,000 | +$215,000 | +59% | 01 Oct 2021 | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY |
| Q3 2021 | $394,000 | $37,000 | +$726,000 | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 14 Nov 2022 | 2022 | Q3 | |
| Q2 2021 | $1,120,000 | $18,000 | +$536,000 | +97% | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 09 Aug 2022 | 2022 | Q2 |
| Q1 2021 | $1,656,000 | $47,000 | +$339,000 | +88% | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 03 May 2022 | 2022 | Q1 |
| Q4 2020 | $1,995,000 | $366,000 | -$539,000 | -312% | 01 Oct 2020 | 31 Dec 2020 | 10-K | 29 Mar 2022 | 2021 | FY |
| Q3 2020 | $1,456,000 | $689,000 | +$147,000 | +18% | 01 Jul 2020 | 30 Sep 2020 | 10-Q | 02 Nov 2021 | 2021 | Q3 |
| Q2 2020 | $1,603,000 | $554,000 | +$215,000 | +28% | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 27 Jul 2021 | 2021 | Q2 |
| Q1 2020 | $1,818,000 | $386,000 | -$371,000 | -2473% | 01 Jan 2020 | 31 Mar 2020 | 10-Q | 13 May 2021 | 2021 | Q1 |
| Q4 2019 | $1,447,000 | $173,000 | -$63,000 | -27% | 01 Oct 2019 | 31 Dec 2019 | 10-K | 16 Mar 2021 | 2020 | FY |
| Q3 2019 | $1,384,000 | $836,000 | -$1,038,000 | -514% | 01 Jul 2019 | 30 Sep 2019 | 10-Q | 09 Nov 2020 | 2020 | Q3 |
| Q2 2019 | $346,000 | $769,000 | -$941,000 | -547% | 01 Apr 2019 | 30 Jun 2019 | 10-Q | 30 Jul 2020 | 2020 | Q2 |
| Q1 2019 | $595,000 | $15,000 | -$81,000 | -123% | 01 Jan 2019 | 31 Mar 2019 | 10-Q | 11 May 2020 | 2020 | Q1 |
| Q4 2018 | $676,000 | $236,000 | +$233,000 | +7767% | 01 Oct 2018 | 31 Dec 2018 | 10-K | 03 Mar 2020 | 2019 | FY |
| Q3 2018 | $443,000 | $202,000 | -$537,000 | -73% | 01 Jul 2018 | 30 Sep 2018 | 10-Q | 30 Oct 2019 | 2019 | Q3 |
| Q2 2018 | $980,000 | $172,000 | +$7,020,000 | 01 Apr 2018 | 30 Jun 2018 | 10-Q | 30 Jul 2019 | 2019 | Q2 | |
| Q1 2018 | $6,040,000 | $66,000 | +$65,000 | +6500% | 01 Jan 2018 | 31 Mar 2018 | 10-Q | 07 May 2019 | 2019 | Q1 |
| Q4 2017 | $6,105,000 | $3,000 | -$300,000 | -99% | 01 Oct 2017 | 31 Dec 2017 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q3 2017 | $5,805,000 | $739,000 | +$303,000 | +69% | 01 Jul 2017 | 30 Sep 2017 | 10-Q | 05 Nov 2018 | 2018 | Q3 |
| Q2 2017 | $6,108,000 | $6,848,000 | -$6,795,000 | -12821% | 01 Apr 2017 | 30 Jun 2017 | 10-Q | 07 Aug 2018 | 2018 | Q2 |
| Q1 2017 | $687,000 | $1,000 | -$103,000 | -99% | 01 Jan 2017 | 31 Mar 2017 | 10-Q | 08 May 2018 | 2018 | Q1 |
| Q4 2016 | $790,000 | $303,000 | +$477,000 | 01 Oct 2016 | 31 Dec 2016 | 10-K | 15 Mar 2018 | 2017 | FY | |
| Q3 2016 | $313,000 | $436,000 | +$672,000 | 01 Jul 2016 | 30 Sep 2016 | 10-K | 15 Mar 2018 | 2017 | FY | |
| Q2 2016 | $359,000 | $53,000 | -$217,000 | -132% | 01 Apr 2016 | 30 Jun 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q1 2016 | $142,000 | $104,000 | +$791,000 | 01 Jan 2016 | 31 Mar 2016 | 10-K | 15 Mar 2018 | 2017 | FY | |
| Q4 2015 | $933,000 | $174,000 | +$878,000 | +83% | 01 Oct 2015 | 31 Dec 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q3 2015 | $1,811,000 | $236,000 | +$4,249,000 | +95% | 01 Jul 2015 | 30 Sep 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q2 2015 | $6,060,000 | $164,000 | +$2,966,000 | 01 Apr 2015 | 30 Jun 2015 | 10-K | 14 Mar 2017 | 2016 | FY | |
| Q1 2015 | $9,026,000 | $687,000 | +$284,000 | +29% | 01 Jan 2015 | 31 Mar 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q4 2014 | $9,310,000 | $1,052,000 | -$1,211,000 | -762% | 01 Oct 2014 | 31 Dec 2014 | 10-K | 23 Feb 2016 | 2015 | FY |
| Q3 2014 | $8,099,000 | $4,485,000 | -$4,723,000 | -1984% | 01 Jul 2014 | 30 Sep 2014 | 10-K | 23 Feb 2016 | 2015 | FY |
| Q2 2014 | $3,376,000 | $2,802,000 | -$2,966,000 | -1809% | 01 Apr 2014 | 30 Jun 2014 | 10-K | 23 Feb 2016 | 2015 | FY |
| Q1 2014 | $410,000 | $971,000 | -$1,306,000 | -390% | 01 Jan 2014 | 31 Mar 2014 | 10-K | 23 Feb 2016 | 2015 | FY |
| Q4 2013 | $896,000 | $159,000 | +$17,000 | +12% | 01 Oct 2013 | 31 Dec 2013 | 10-K | 24 Feb 2015 | 2014 | FY |
| Q3 2013 | $879,000 | $238,000 | +$601,000 | 01 Jul 2013 | 30 Sep 2013 | 10-K | 24 Feb 2015 | 2014 | FY | |
| Q2 2013 | $278,000 | $164,000 | +$538,000 | 01 Apr 2013 | 30 Jun 2013 | 10-K | 24 Feb 2015 | 2014 | FY | |
| Q1 2013 | $260,000 | $335,000 | +$896,000 | 01 Jan 2013 | 31 Mar 2013 | 10-K | 24 Feb 2015 | 2014 | FY | |
| Q4 2012 | $1,156,000 | $142,000 | +$591,000 | 01 Oct 2012 | 31 Dec 2012 | 10-K | 25 Feb 2014 | 2013 | FY | |
| Q3 2012 | $1,747,000 | $363,000 | -$1,000 | -0.28% | 01 Jul 2012 | 30 Sep 2012 | 10-K | 25 Feb 2014 | 2013 | FY |
| Q2 2012 | $1,746,000 | $374,000 | -$10,000 | -2.7% | 01 Apr 2012 | 30 Jun 2012 | 10-K | 25 Feb 2014 | 2013 | FY |
| Q1 2012 | $1,736,000 | $561,000 | -$222,000 | -65% | 01 Jan 2012 | 31 Mar 2012 | 10-K | 25 Feb 2014 | 2013 | FY |
| Q4 2011 | $1,514,000 | $449,000 | 01 Oct 2011 | 31 Dec 2011 | 10-K | 05 Mar 2013 | 2012 | FY | ||
| Q3 2011 | $362,000 | +$37,268 | +9.3% | 01 Jul 2011 | 30 Sep 2011 | 10-K | 05 Mar 2013 | 2012 | FY | |
| Q2 2011 | $364,000 | +$44,185 | +11% | 01 Apr 2011 | 30 Jun 2011 | 10-K | 05 Mar 2013 | 2012 | FY | |
| Q1 2011 | $339,000 | 01 Jan 2011 | 31 Mar 2011 | 10-K | 05 Mar 2013 | 2012 | FY | |||
| Q3 2010 | $399,268 | 01 Jul 2010 | 30 Sep 2010 | 10-Q | 08 Nov 2011 | 2011 | Q3 | |||
| Q2 2010 | $408,185 | 01 Apr 2010 | 30 Jun 2010 | 10-Q | 09 Aug 2011 | 2011 | Q2 |
INFINITY PHARMACEUTICALS, INC. Annual Nonoperating Income (Expense) (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2022 | $475,000 | +$654,000 | 01 Jan 2022 | 31 Dec 2022 | 10-K | 28 Mar 2023 | 2022 | FY | |
| 2021 | $179,000 | +$1,816,000 | +91% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY |
| 2020 | $1,995,000 | -$548,000 | -38% | 01 Jan 2020 | 31 Dec 2020 | 10-K | 29 Mar 2022 | 2021 | FY |
| 2019 | $1,447,000 | -$2,123,000 | -314% | 01 Jan 2019 | 31 Dec 2019 | 10-K | 16 Mar 2021 | 2020 | FY |
| 2018 | $676,000 | +$6,781,000 | 01 Jan 2018 | 31 Dec 2018 | 10-K | 03 Mar 2020 | 2019 | FY | |
| 2017 | $6,105,000 | -$6,895,000 | -873% | 01 Jan 2017 | 31 Dec 2017 | 10-K | 14 Mar 2019 | 2018 | FY |
| 2016 | $790,000 | +$1,723,000 | 01 Jan 2016 | 31 Dec 2016 | 10-K | 15 Mar 2018 | 2017 | FY | |
| 2015 | $933,000 | +$8,377,000 | +90% | 01 Jan 2015 | 31 Dec 2015 | 10-K | 15 Mar 2018 | 2017 | FY |
| 2014 | $9,310,000 | -$10,206,000 | -1139% | 01 Jan 2014 | 31 Dec 2014 | 10-K | 14 Mar 2017 | 2016 | FY |
| 2013 | $896,000 | +$2,052,000 | 01 Jan 2013 | 31 Dec 2013 | 10-K | 23 Feb 2016 | 2015 | FY | |
| 2012 | $1,156,000 | +$358,000 | +24% | 01 Jan 2012 | 31 Dec 2012 | 10-K | 24 Feb 2015 | 2014 | FY |
| 2011 | $1,514,000 | -$801,000 | -112% | 01 Jan 2011 | 31 Dec 2011 | 10-K | 25 Feb 2014 | 2013 | FY |
| 2010 | $713,000 | 01 Jan 2010 | 31 Dec 2010 | 10-K | 05 Mar 2013 | 2012 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.